News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Coronado Biosciences to Present at the Wedbush Life Sciences Management Access Conference


8/6/2012 9:13:50 AM

BURLINGTON, Mass., Aug. 6, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado's President and CEO, will present at the Wedbush Life Sciences Management Access Conference on Wednesday, August 15, 2012 at 9:45 AM ET. The conference will be held August 14-15, 2012 at Le Parker Meridien in New York City.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES